As States Target High Drug Prices, Pharma Targets State Lawmakers
By Jay Hancock and Shefali Luthra
In Louisiana, the wining and dining of lawmakers by scores of pharma lobbyists proves a valuable lesson on how to win statehouse votes and influence profits, though their efforts fell short in California, which passed a drug transparency bill in 2017 despite massive opposition from drugmakers.